• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLIFT WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94703RX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Foreign Body Reaction (1868)
Event Date 03/10/2021
Event Type  Injury  
Manufacturer Narrative
Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The events are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.The filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional (hcp) reported that the patient was injected in the lips with juvéderm® volift¿ with lidocaine with adequate initial evolution, little inflammation and satisfaction of size and shape.Over 9 months later patient noticed a formation of pimple on the lower lip mucosa on the right side, which increased in size, until patient noticed a violent accumulation.Patient attending consultation for mucosa injuries of the lower lip for several weeks with inflammation and associated pain.Patient consulted a dermatologist who performed an incisional biopsy (resection of the nodular injury was performed in the mucosa of lower lip on the left side) that reported granulomatous dermatitis secondary to the presence of external material.Study material was sent to immunohistochemical.Treatment with oral antibiotic and anti-inflammatory were given.¿presents scar in mucosa of lower lip with lower nodular injury of approximately 6 mm, without signs of overinfection¿ was noted during examination.Hcp assessed and found ¿an inflammatory nodule with an accumulation of yellowish material seen through the mucosa of the lower lip on the right side, not observed from the outside.It is also observed that the periodontal area is demarcated (diagnosis of bruxism).Asepsis and antisepsis, application of 2% lidocaine, little purulent material is extracted, observing a decrease in nodulation.Foreign body granuloma of skin and subcutaneous tissue was noted as diagnosis.Injected 3u of hyaluronidase with which the nodulation decreases remarkably.On the following day patient reported to feel better.2 days later the granuloma was observed smaller in size.3u hyaluronidase injected with good response.The nodule is reduced following application of hyaluronidase, but no more than 8 days pass by and it reappears.It is smaller in size.The symptom has improved but not resolved.This is the same event and the same patient reported under emdr-00457 (allergan complaint # (b)(4)), emdr-00760 (allergan complaint # (b)(4)), emdr-00761 (allergan complaint # (b)(4)), and mfr report # 3005113652-2021-00408, emdr-00763 (allergan complaint # (b)(4)).This emdr is being submitted for the second suspect product, juvéderm® volift¿ with lidocaine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLIFT WITH LIDOCAINE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
PRINGY
route de promery
zone artisanale de pre-mairy
FR  
Manufacturer Contact
chris sprague
12331-a riata trace parkway
austin, TX 
8479375615
MDR Report Key11820671
MDR Text Key265210946
Report Number3005113652-2021-00409
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodeCO
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/29/2020
Device Catalogue Number94703RX
Device Lot NumberV17LA80198
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age42 YR
-
-